SDC1 and neoplasm: Finally, performing an in silico analysis with public databases from TCGA and GEO (cohorts GSE9891, GSE3149, GSE26193, and GSE63885), the authors found that syndecan-1 expression level negatively correlated with OS in OC patients and that syndecan-4 expression increased across tumor stage.